Literature DB >> 9020173

Accumulation of E2F-4.DP-1 DNA binding complexes correlates with induction of dhfr gene expression during the G1 to S phase transition.

J M Wells1, S Illenye, J Magae, C L Wu, N H Heintz.   

Abstract

Previously genomic DNase I footprinting showed changes in protein binding to two overlapping E2F sites correlates with activation of dhfr gene expression at the G1/S boundary of the Chinese hamster cell cycle (Wells, J., Held, P., Illenye, S., and Heintz, N. H. (1996) Mol. Cell. Biol. 16, 634-647). Here gel mobility and antibody supershift assays were used to relate changes in the components of E2F DNA binding complexes in cell extracts to repression and induction of dhfr gene expression. In extracts from log phase cells, E2F complexes contained predominantly E2F-4 and E2F-2 in association with DP-1, and DNA binding assays showed complexes containing E2F-2 preferentially interact with only one of the two overlapping E2F sites. In serum starvation-stimulation experiments, arrest in G1 by low serum was accompanied by decreased levels of dhfr mRNA and the appearance of an E2F-4.DP-1.p130 complex. After serum stimulation, induction of dhfr gene expression was preceded by loss of the p130 complex in mid G1 and coincided with marked increases in two free E2F.DP-1 complexes in late G1, one of which contained E2F-4 and a second which contained an unidentified E2F. We suggest activation of dhfr gene expression after serum stimulation requires at least two temporally distinct processes, relief of p130-mediated repression and subsequent activation of transcription by free E2F.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020173     DOI: 10.1074/jbc.272.7.4483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

Authors:  J Zhao; B K Kennedy; B D Lawrence; D A Barbie; A G Matera; J A Fletcher; E Harlow
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

3.  Analysis of the cell cycle regulatory protein (E2F1) after infection of cultured cells with bovine herpesvirus 1 (BHV-1) or herpes simplex virus type 1 (HSV-1).

Authors:  Aspen Workman; Clinton Jones
Journal:  Virus Res       Date:  2011-05-23       Impact factor: 3.303

4.  Subunit composition determines E2F DNA-binding site specificity.

Authors:  Y Tao; R F Kassatly; W D Cress; J M Horowitz
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 5.  E2F transcription factor action, regulation and possible role in human cancer.

Authors:  T L Sladek
Journal:  Cell Prolif       Date:  1997 Mar-Apr       Impact factor: 6.831

6.  Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene.

Authors:  Y C Chang; S Illenye; N H Heintz
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  The Chinese hamster dihydrofolate reductase replication origin decision point follows activation of transcription and suppresses initiation of replication within transcription units.

Authors:  Takayo Sasaki; Sunita Ramanathan; Yukiko Okuno; Chiharu Kumagai; Seemab S Shaikh; David M Gilbert
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

8.  Cell cycle regulation of the tobacco ribonucleotide reductase small subunit gene is mediated by E2F-like elements.

Authors:  M E Chabouté; B Clément; M Sekine; G Philipps; N Chaubet-Gigot
Journal:  Plant Cell       Date:  2000-10       Impact factor: 11.277

9.  Productive infection and bICP0 early promoter activity of bovine herpesvirus 1 are stimulated by E2F1.

Authors:  Aspen Workman; Clinton Jones
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.